Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.87+0.02 (+0.41%)
Close on Nov 17, 2026Market cap $804.72MP/E 6.3Yield –
Ironwood Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ironwood Pharmaceuticals's market cap was $794.80M on Nov 10, 2026, against $569.38M a year earlier. Over the last 5 years it ranged from $96.94M to $2.22B, with a median of $1.09B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | $794.80M | +45.0% |
| 2025 | Dec 31, 2025 | $548.23M | -22.7% |
| 2024 | Dec 31, 2024 | $708.87M | -60.3% |
| 2023 | Dec 29, 2023 | $1.79B | -6.0% |
| 2022 | Dec 30, 2022 | $1.90B | -0.3% |
| 2021 | Dec 31, 2021 | $1.91B | +4.5% |
| 2020 | Dec 31, 2020 | $1.82B | -12.6% |
| 2019 | Dec 31, 2019 | $2.09B | +305.4% |
| 2017 | Jan 31, 2017 | $514.78M | -6.0% |
| 2016 | Dec 30, 2016 | $547.35M | -55.4% |
| 2015 | Dec 31, 2015 | $1.23B | -39.4% |
| 2014 | Dec 31, 2014 | $2.02B | +111.8% |
| 2013 | Dec 31, 2013 | $955.32M | -19.0% |
| 2012 | Dec 31, 2012 | $1.18B | -0.9% |
| 2011 | Dec 30, 2011 | $1.19B | +1515.5% |
| 2010 | Dec 31, 2010 | $73.66M | – |
See a number that looks wrong?